ELISA kit for Pig Antibody against Foot and Mouth Disease IgG (FMDV-Ab-IgG) |
KTE80190-48T |
Abbkine |
48T |
EUR 464.4 |
|
Description: Quantitative sandwich ELISA for measuring Pig Antibody against Foot and Mouth Disease IgG (FMDV-Ab-IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Cytomegalovirus Antibody Laboratories manufactures the cytomegalivirus igg ab reagents distributed by Genprice. The Cytomegalivirus Igg Ab reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalivirus products are available in stock. Specificity: Cytomegalivirus Category: Igg Group: Ab
Human Legionella antibody IgG,LP Ab-IgG ELISA Kit |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Ab information
Mouse cytomegaloviruses PCR kit |
PCR-V367-96D |
Bioingentech |
100T |
EUR 686.4 |
Mouse cytomegaloviruses RT PCR kit |
RTq-V367-100D |
Bioingentech |
100T |
EUR 860.4 |
Mouse cytomegaloviruses RT PCR kit |
RTq-V367-150D |
Bioingentech |
150T |
EUR 969.6 |
Mouse cytomegaloviruses RT PCR kit |
RTq-V367-50D |
Bioingentech |
50T |
EUR 717.6 |
Cytomegalo Virus gB (Recombinant) |
22060043-1 |
Glycomatrix |
100 µg |
EUR 217.9 |
Cytomegalo Virus gB (Recombinant) |
22060043-2 |
Glycomatrix |
500 µg |
EUR 601.12 |
Cytomegalo Virus gB (Recombinant) |
22060043-3 |
Glycomatrix |
1000 µg |
EUR 1106.33 |
Cytomegalovirus pp65 Antibody |
abx021650-1mg |
Abbexa |
1 mg |
EUR 1387.2 |
|
Cytomegalovirus Pp28 (UL99) Protein |
20-abx260106 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Cytomegalovirus Pp52 (UL44) Protein |
20-abx260108 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Cytomegalovirus Pp65 (UL83) Protein |
20-abx260109 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Virus Cytomegalovirus (CMV) Protein |
abx670257-1ml |
Abbexa |
1 ml |
EUR 493.2 |
|
Cytomegalovirus Antibody / CMV / PP65 |
V2332-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |